BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 891025)

  • 1. Acute hepatitis: significance of changes in complement components.
    Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
    Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complement C3 and C4 levels in serum from acute viral hepatitis].
    Ozer FT; Barut A; Inal A; Hacibektaşoğlu A
    Mikrobiyol Bul; 1992 Oct; 26(4):314-9. PubMed ID: 1435361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles infection. Involvement of the complement system.
    Charlesworth JA; Pussell BA; Roy LP; Robertson MR; Beveridge J
    Clin Exp Immunol; 1976 Jun; 24(3):401-6. PubMed ID: 939047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of urticaria and acute serum sickness with the C1q precipitin test.
    Lieberman P; Rice MC; Mallette JE
    Arch Intern Med; 1977 Apr; 137(4):440-2. PubMed ID: 139855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement study in 40 children with acute and chronic viral hepatitis of HB origin].
    Dupuy C; Lafforêt D; Dupuy JM
    Arch Fr Pediatr; 1977; 34(7 Suppl):CLXXXIV-CXCVI. PubMed ID: 931524
    [No Abstract]   [Full Text] [Related]  

  • 8. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes.
    Wands JR; Alpert E; Isselbacher KJ
    Gastroenterology; 1975 Dec; 69(6):1286-91. PubMed ID: 1193327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.
    Wands JR; Mann E; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):930-6. PubMed ID: 1123429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behaviour of chosen acute phase proteins in acute viral type B hepatitis as a predictive factor of further evolution of the infection.
    Paszkiewicz J
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):267-73. PubMed ID: 7510472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in Indian childhood cirrhosis.
    Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
    Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune complexes in viral hepatitis. Fulminating hepatitis].
    Guardia J; Martinez-Vazquez JM; Marsal J; Ferragut A; Bacardi R
    Nouv Presse Med; 1972 Jun; 1(26):1763-8. PubMed ID: 4626551
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis.
    Kitamura H; Nagaki K; Inoshita K; Iida K; Inai S
    Clin Exp Immunol; 1977 Jan; 27(1):34-7. PubMed ID: 849648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum complement level in dengue hemorrhagic fever.
    Nishioka K
    Allerg Immunol (Leipz); 1974-1975; 20-21(4):385-92. PubMed ID: 4283486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.